Curevac N V Quick Ratio (CVAC) starting from the second quarter 2025 to second quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Curevac N v   (NASDAQ: CVAC)

Curevac N V 's Quick Ratio

CVAC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2025, Quick Ratio fell to 5.88 above Curevac N V average.

Within Major Pharmaceutical Preparations industry 171 other companies have achieved higher Quick Ratio than Curevac N V in second quarter 2025. While Quick Ratio total ranking in the second quarter 2025 has deteriorated compared to the prior quarter from 683 to 736.

Explain Quick Ratio?
How much Cash & cash equivalents CVAC´s has?
What are CVAC´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CVAC Quick Ratio (Jun 30 2025)
Q2		 (Mar 31 2025)
Q1		 (Dec 31 2024)
Q4		 0
Q3		 0
Q2
Y / Y Current Liabilities Change -1.2 % -18.34 % -61.18 % -61.18 % -61.18 %
Y / Y Cash & cash equivalent Change -13.78 % -11.99 % 19.6 % 19.6 % 19.6 %
Quick Ratio MRQ 5.88 7.26 6.74 6.74 6.74
CVAC's Total Ranking # 736 # 683 # 702 # 718 # 1753
Seq. Current Liabilities Change 20.99 % -18.34 % 0 % 0 % 0 %
Seq. Cash & cash equivalent Change -2.03 % -11.99 % 0 % 0 % 0 %



Quick Ratio second quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 172
Healthcare Sector # 289
Overall Market # 796


Quick Ratio Statistics
High Average Low
7.26 4.11 0.43
(Mar 31 2025)   (Dec 31 2019)




Financial Statements
Curevac N V 's Current Liabilities $ 80 Millions Visit CVAC's Balance sheet
Curevac N V 's Cash & cash equivalent $ 471 Millions Visit CVAC's Balance sheet
Source of CVAC's Sales Visit CVAC's Sales by Geography


Cumulative Curevac N V 's Quick Ratio

CVAC's Quick Ratio for the trailling 12 Months

CVAC Quick Ratio

 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months		 0
12 Months		 0
12 Months
Y / Y Current Liabilities TTM Growth -46.81 % -56.28 % -61.18 % -43.05 % -23.06 %
Y / Y Cash & cash equivalent TTM Growth 1.91 % 10.59 % 19.6 % 10.22 % 1.63 %
Quick Ratio TTM 6.63 6.85 6.74 4.64 3.46
Total Ranking TTM # 172 # 683 # 702 # 718 # 793
Seq. Current Liabilities TTM Growth -0.31 % -4.59 % -28.27 % -22.04 % -18.06 %
Seq. Cash & cash equivalent TTM Growth -3.55 % -3 % 4.27 % 4.46 % 4.67 %

Quick ratio ranking by company, industry and sector >> Back to CVAC Financial Strength Comparisons >> Go to Compare CVAC Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CVAC's Current Liabilities to $80.06 millions, cumulative Quick Ratio to 6.63 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 493 other companies have achieved higher Quick Ratio than Curevac N V . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2025 at 3579.

Explain Quick Ratio?
How much Cash & cash equivalents CVAC´s has?
What are CVAC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 494
Healthcare Sector # 986
Within the Market # 736


trailing twelve months Quick Ratio Statistics
High Average Low
6.66 4 2.16
(Dec 31 2024)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2025, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2025 MRQ Cash & cash equivalentJun 30 2025 MRQ Current Liabilities
Mereo Biopharma Group Plc  16.00 $ 77.417  Millions$ 4.838  Millions
Oric Pharmaceuticals Inc   15.65 $ 282.513  Millions$ 18.050  Millions
Moonlake Immunotherapeutics  15.54 $ 425.083  Millions$ 27.361  Millions
Nkarta Inc   15.31 $ 289.687  Millions$ 18.927  Millions
Liquidia Corporation  15.28 $ 173.422  Millions$ 11.346  Millions
Pulmatrix Inc   15.17 $ 5.825  Millions$ 0.384  Millions
Galera Therapeutics Inc   15.07 $ 5.230  Millions$ 0.347  Millions
Tao Synergies Inc   14.90 $ 14.370  Millions$ 0.964  Millions
Xenon Pharmaceuticals Inc   14.75 $ 487.545  Millions$ 33.047  Millions
Verona Pharma Plc  14.74 $ 438.016  Millions$ 29.712  Millions
Siga Technologies Inc  14.62 $ 182.463  Millions$ 12.478  Millions
Eupraxia Pharmaceuticals Inc   14.52 $ 80.563  Millions$ 5.550  Millions
Astria Therapeutics Inc   14.36 $ 259.178  Millions$ 18.044  Millions
Cryoport inc   14.20 $ 428.071  Millions$ 30.149  Millions
89bio Inc   14.17 $ 561.164  Millions$ 39.611  Millions
Rezolute Inc   14.09 $ 167.858  Millions$ 11.912  Millions
Lava Therapeutics Nv  13.97 $ 82.580  Millions$ 5.912  Millions
Aprea Therapeutics Inc   13.82 $ 16.532  Millions$ 1.196  Millions
Boundless Bio Inc   13.80 $ 127.148  Millions$ 9.213  Millions
Aardvark Therapeutics Inc   13.76 $ 141.820  Millions$ 10.310  Millions
Climb Bio Inc   13.65 $ 84.703  Millions$ 6.205  Millions
Nuvalent Inc   13.38 $ 1,005.598  Millions$ 75.147  Millions
Lite Strategy Inc   13.30 $ 18.011  Millions$ 1.354  Millions
Cartesian Therapeutics Inc   13.08 $ 160.324  Millions$ 12.256  Millions
Rapt Therapeutics Inc   12.95 $ 168.947  Millions$ 13.043  Millions
Medicinova Inc   12.94 $ 34.260  Millions$ 2.648  Millions
Eledon Pharmaceuticals Inc   12.92 $ 209.429  Millions$ 16.211  Millions
Arvinas Inc   12.83 $ 861.200  Millions$ 67.100  Millions
Dianthus Therapeutics Inc   12.81 $ 257.389  Millions$ 20.093  Millions
Pliant Therapeutics Inc   12.77 $ 262.873  Millions$ 20.591  Millions

Date modified: 2026-09-18T16:09:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.